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Iain S. Whitaker, BA(Hons), MA, Cantab MBBChir MRCS, PhD, FRCS, Plast,†
Daniel Chubb, MBBSB, MedSc,‡ Damien Grinsell, MBBS, FRACS,‡Mark W. Ashton, MBBS, MD, FRACS,‡
David J. Hunter-Smith, MBBS(Hon), MPH, FRACS, FACS,* and William C. Lineaweaver, MD, FACS§
Background: Despite a plethora of monitoring techniques reported in the litera-
ture, only a small number of studies directly address clinical relevant end points,
such as the flap salvage rate and false-positive rate.
Method:We conducted a systematic reviewof current evidence regarding the post-
operative monitoring of microvascular free-tissue transfer via extensive electronic
and manual search and perusing databases, such as PubMed, Cochrane, American
College of Physicians (ACP) Journal Club, Cumulative Index of Nursing and
Allied Health Literature (CINAHL), Excerpta Medica Database (EMBASE),
and Ovid MEDLINE. The included literature (n = 184 publications) was criti-
cally appraised using March 2009 Oxford Centre for Evidence-Based Medicine
definitions, focusing on the evidence for the efficacy of each technique in im-
proving the flap salvage rate of compromised flaps.
Result: There is a paucity of outcome-based studies, with only implanted Doppler
probes, near-infrared spectroscopy, laser Doppler flowmetry, quantitative fluo-
rimetry, and digital photography assessment using smartphones having been
demonstrated in comparative studies to improve flap salvage rate. Currently,
the implantable Doppler probe is the technique with the largest number of com-
parative studies and case series to demonstrate its effectiveness compared with
clinical monitoring.
Conclusions: Future studies need to evaluate the most promising monitoring
techniques further with a focus on assessing clinically relevant outcomes, such
as the flap salvage rate and the false-positive rate, and not simple clinical series
reporting patient and physician satisfaction.
(Ann Plast Surg 2015;74: 621–632)
A ided by surgical and technical advancements, success rates formicrosurgical flap procedures are generally reported to be 95%
or greater.1–4 Preoperative assessment of the flap vasculature aids in
flap territory selection and may contribute to improvement in flap
outcomes,5–7 whereas intraoperative evaluation of pedicle and flap per-
fusion has allowed for greater confidence in the viability of larger free
flaps.8 Moreover, evidence suggests that correction of an intraoperative
flow problem is associated with decreased risk of postoperative vascu-
lar complications.9,10
There remains, however, a small but significant flap failure rate,
even in the hands of the most experienced surgeons. The use of clinical
monitoring has been shown to salvage some of these threatened flaps,
with some experienced groups showing that salvage of approximately
70% to 80% of compromised free flaps is possible.11–14
Flap failures may be attributed to arterial or venous occlusion aris-
ing from thrombosis, external compression, vessel kinking, or hema-
toma. Available evidence and expert opinions both indicate that timely
detection of flap compromise and subsequent reexploration significantly
increases the rate of flap salvage.15–18 This need for early diagnosis and
management of vascular complications in free flaps has led to a plethora
of monitoring techniques being studied and assessed clinically.
A broad range of different technologies has been described for
this role, but few studies use a significant clinical outcome as the pri-
mary end point of the trial. As such, there is little substantial evidence
for any particular technique. Surveys of plastic surgical units show sub-
stantial differences in the selected methods and implementation of
monitoring after free-tissue transfer,19–21 suggesting that there is no cur-
rently established standard method for monitoring free flaps.
The purpose of flap monitoring is to rapidly identify circulatory
compromise. It has been known for many years that flap ischemia
becomes irreversible after a short period.22–24 The no-reflow phenome-
non described in 1978,25 was a significant confirmation that reversibil-
ity was closely related to the ischemic time, with the hope of flap
salvage eliminated after only a few hours of microvascular thrombosis
and tissue ischemia.
Creech and Miller outlined essential criteria for free-flap moni-
toring,26 stating that an ideal monitoring technique should be:
– Harmless to the patient and free flap.
– Rapid, repeatable, reliable, recordable, and rapidly responsive.
– Accurate and inexpensive.
– Objective and applicable to all kinds of flaps.
– Equipped with a simple display that could alert relatively inexperi-
enced personnel to the development of circulatory impairment.
There have been several descriptions in the literature of the
optimal comparative measures for evaluating adjunctive monitoring
techniques.26–28 The optimal test for monitoring efficacy is the sal-
vage rate, which is the ability of a monitoring technique to allow
early intervention and salvage of a truly compromised flap. This
measure encompasses both the sensitivity of the method as well as
its clinical importance. The other major measure of efficacy is the
false-positive rate, which is a measure of the rate of precipitating
needless take backs to the operating theater.27,28 The use of these
outcome measures can then enable assessment of a technique against
the use of no monitor at all.
At this time, only a small number of studies show any technique
to be better than basic clinical monitoring in terms of reexplorative
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outcome.28–37 There are many anecdotal reports that claim that some
devices managed to determine flap compromise earlier than clinical
monitoring,38–44 but this apparent performance was not associated
with improved flap salvage or other measureable outcomes.37–43 Com-
parisons of large studies using different monitoring techniques reveal
similar flap success rates (97%-99%) and salvage rates (up to 80%), re-
gardless of the monitoring system used.1,3,5,10,32–47
This review has been undertaken to clarify the currently available
evidence related to postoperative flap monitoring.
METHODS
We performed a systematic review to evaluate the current evi-
dence regarding postoperative monitoring of microvascular free flap
transfer with an electronic and manual search, using the search string
“flap ANDmonitoring.” The inclusion criteriawas simple: any publica-
tion directly studying or commenting on the use of free flap monitoring
techniques of any kind were included in this review. We perused the
following electronic databases: PubMed, PubMed Central, Cochrane
Database of Systematic Reviews, American College of Physicians
Journal Club, Database of Abstracts of Reviews of Effects, Cochrane
Central Register of Controlled Trials, Cochrane Methodology Register,
Allied and Complementary Medicine, Cumulative Index of Nursing and
Allied Health Literature, Excerpta Medica Database, Ovid MEDLINE
in-process, and other non-indexed citations. To avoid the language bias,
we included articles in English, Italian, French, Spanish, and German.
Secondary references found through bibliographic linkage were also
retrieved. The literature identified was critically evaluated based on
the March 2009 Oxford Centre for Evidence-Based Medicine (CEBM)
definitions.48
RESULTS
Clinical Monitoring
Clinical bedside monitoring is the current standard for flap
monitoring, used by almost all microsurgical units.19–21 It involves using
the flap color, temperature, capillary refill, skin turgor, hand-held
Doppler findings, and pinprick as measures of adequate perfusion of
the flap. Regular monitoring during the first few days postoperatively
has enabled some units to produce flap salvage rates of up to 80%
and overall success rates of up to 99%.1,14 Reviews of multiple large
case series shows that salvage rates range from 40% to 80% and overall
success rates range from 94% to 99%,1,4,14,49–55 but these case series
are not necessarily monitored in a standard way, or monitored at all.
The only large series of clinically monitored cases published are those
by Disa et al and Chubb et al. The study of Disa et al14 comprised a ret-
rospective review of 750 cases and emphasized the importance of clin-
ical monitoring through the observation that there was 0% salvage rate
of all unmonitored buried free flaps with a compromised microcircula-
tion, clearing showing the need for effective clinical monitoring. Chubb
et al reviewed 1140 cases and showed that venous thrombosis has a sig-
nificantly greater salvage prognosis than arterial, and that the recipient
site for the free flap has implications on the false-positive rate for clin-
ical monitoring, with flaps used on extremities more likely to be
inadvisably reexplored.54
One of the significant limitations of the standard clinical moni-
toring techniques is the inability to examine flaps that are buried or
located in difficult to access areas. In the literature, investigators have
bypassed this issue by creating a distal skin paddle,56–59 a chimeric
flap,60–62 or an exteriorized flap,63–66 on which the usual clinical exam-
inations can be performed. Such “monitoring flaps” provide an indirect
indication about the perfusion status of the flap of interest. However,
any derivation must be carefully interpreted caused by the potential risk
of a false-positive or -negative result arising from vascular complica-
tions specific to the “monitoring flap.”62
Clinical monitoring provides a standard against which adjunctive
and alternative monitoring techniques must be compared. To date, only
a few techniques have been shown to improve flap salvage rates in com-
parison to clinical monitoring, and all of these case series have based
their analysis on small numbers of failing flaps.29–38
The Cook-Swartz Implantable Doppler Probe
An implantable Doppler probe was first used in free flap moni-
toring in 1984,67 and the Cook-Swartz probe was first developed in
1988 specifically for use in free flap operations.68 A Cook-Swartz
implantable Doppler probe directly measures the blood flow in the ped-
icle and consists of a silicone cuff approximately 5 mm in width con-
taining a 20-MHz piezoelectric crystal. The cuff is secured around the
venous pedicle using microclips,69 sutures,70 a fibrin sealant,71 or an
elongated silicone cuff.72,73 Earlier studies placed the probe around arte-
rial pedicle, but subsequent studies demonstrated that it is more sensitive
when placed on the venous anastomosis.73 AvenousDoppler signal im-
mediately detects both venous and arterial blood flow obstruction. In
contrast, an arterial Doppler signal can detect arterial compromise in-
stantaneously, but venous occlusion would only be identifiable after
3 to 4 hours.73 The probe's proximal end exits the surgical wound as
a thin wire and is connected to a transportable monitor at the bedside.
The wire is usually sutured to the patient in order to prevent accidental
pulling leading to false-negative results. At 5 to 10 days postoperatively,
depending on the length of direct vessel monitoring required by the sur-
geon, the electrode can be pulled free from the cuff when a tension of
50 g is applied.
There have been 6 comparative studies of the implanted Doppler
probe in free flap monitoring.29–32,46,74 In 4 studies, the implanted
Doppler probe has demonstrated an increase in the flap salvage rate
compared to standard clinical monitoring.29–32 All of these studies have
small numbers of flap salvage attempts (n = 20, 10, 35, 33), and statis-
tical significance is only achieved in one of them.30 However, a meta-
analysis of 547 consecutive patients from the first 3 studies by Rozen
et al30 produced a statistically significant improvement in the salvage
rate (80% vs 66%). In addition, Frost et al.73 have prospectively compared
the Cook-Swartz Doppler probe, microdialysis, and clinical monitoring,
and demonstrated that both devices indicate vascular compromise sta-
tistically earlier than clinical signs, but the study was not sufficiently
powered to demonstrate an improvement in the flap salvage rate using
this technique.74 Um et al46 have compared the effectiveness of the im-
planted probe to the Synovis Flow Coupler in 220 free flaps (Synovis
Life Technologies, Inc., Minneapolis, MN). The latter is a device that
combines an end-to-end anastomotic coupler with a removable 20 MHz
Doppler probe enabling the vascular anastomosis and the probe instal-
lation to be performed simultaneously and, thus, saving intraoperative
time.47,75,76 The authors demonstrate no statistically significant differ-
ence between the Cook-Swartz Doppler probe and the Synovis Flow
Coupler in the false-positive rate (0.9% vs 1.8%, respectively) and the
flap salvage rate (82% vs 80%, respectively). The authors did not dem-
onstratewhether these high flap salvage rates represent an improvement
from the standard clinical monitoring.
There are also 4 series of reexplorations (n = 9, 19, 18, 77) asso-
ciated with the use of the implanted Doppler probe showing salvage
rates of 83, 94, 61, and 56%, respectively.10,46,77,78 Interestingly, only
2 of the studies demonstrate rates better than literature values for clinical
monitoring.46,77 However, the other 2 studies report reasonable sensi-
tivity (67% and 87%, respectively) and high specificity (95% and
99%, respectively) of the technique, and it can be concluded that the
implanted Doppler probes are still accurate and effective.10,77 Further-
more, the implanted Doppler probes are especially beneficial in moni-
toring buried free flaps or cutaneous flaps that are located in poorly
accessible areas. Schmulder et al32 reported that the difference in the
flap salvage rate between the implanted Doppler probe and clinical
monitoring is even greater in buried flaps (94% vs 40%).32
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The implantable Doppler probes are also the most cost-effective
postoperative free flap monitoring technique.78 Implantable Doppler
probes are financially more advantageous if the rate of flap failure
before reexploration is 6% to 10% or greater.79
The Cook-Swartz probe is associated with a small false-positive
rate,29,79,80 and initial studies reported a low rate of probe malfunction,
which was thought to be due to a learning curve for the surgeons in
placing the probe around the venous pedicle.45,61,68,73,81,82 Later studies
have not reported this problem, and recently published reports indicate
that the device can be easily and reliably secured.69 Interestingly, Kim
et al81 describe a novel technique in a small case series where the probe
is placed on a chimeric flap to yield a surrogate measure of flow, pre-
venting excessive tension on the anastomosis.83 However, this method
introduces an additional operative time by raising a chimeric flap and
potentially increases the donor site morbidity. More clinical studies will
be required to validate this technique. Recent studies by Paydar et al76
and Schmulder et al32 report that a small number of false-positive cases
can still arise because of the subjective interpretation of the Doppler
signal by an inexperienced healthcare professional.
The optimal use of the Cook-Swartz Doppler probe requires ad-
equately trained health care personnel and reliable application on the
venous pedicle. It should be used to replace the clinical examinations
in buried and poorly accessible flaps and, when in doubt, needs to be
complemented by clinical monitoring and handheld Doppler.78,81
Microdialysis
First described in the setting of free flap monitoring by Udesen
et al,84 microdialysis consists of a double-lumen catheter with a semi-
permeable membrane at the end, which is placed within the flap to be
monitored, and a small amount of fluid is pumped through the catheter.
As this fluid passes through the semipermeable membrane, small mol-
ecules may pass into the dialysate, which can then be analyzed. The
level of certain metabolites within the transferred tissue can be used
to ascertain its metabolic state. Typical metabolites used for this tech-
nique are lactate, glucose, glycerol, and pyruvate.84–86 Several other mol-
ecules, such as complement 3a and thromboxane A2, have been mooted
as candidates for further study.87,88 Udesen et al used a similar catheter
placed elsewhere in the body for a reference comparison, whereas some
later studies have simply compared results to reference values or used
increasing lactate/pyruvate ratios as a measure of ischemia. In a recent
animal study, Kristensen et al89 demonstrated that using lactate and glu-
cose levels, lactate-to-glucose ratio, and glucose challenge test, they could
differentiate between ischemic and non-ischemic flaps, and identify
hematoma. In a large retrospective analysis of 268 free flaps, Setala and
Gudaviciene89 concluded that high lactate:glucose ratio can be used to
predict total or partial flap necrosis requiring reexploration.90
Major advantages associated with microdialysis are that it pro-
vides an accurate, objective measure of the flap metabolism in ischemia
and produces a timely and sensitive indication of flap failure.91,92 Similar
to the implantable Doppler probes, it is potentially useful in buried flaps
and cutaneous flaps that are difficult to examine.93,94 Edsander-Nord
et al84 have illustrated the sensitivity of this technique by showing that
microdialysis can detect a difference in metabolism between free and
pedicled transverse rectus abdominis myocutaneous flaps, and between
zones I and II of the same group of flaps.85 Sorensen95 successfully
used microdialysis in buried free jejunal transfers to identify flap com-
promise early and salvage 2 such flaps. Mourouzis et al96 published a
case report where they used microdialysis to monitor a bone-only free
flap in which no compromise occurred. Jyranki et al97 reported a case
series of free flaps, and found in 2 cases that metabolic changes can
be detected before the clinical signs, although both of these flaps failed
after reexploration. Several other authors have concluded that microdi-
alysis is a method that can give early warning of flap failure.84,98
There have been 2 trials comparing microdialysis to other moni-
toring techniques.74,86Whitaker et al86 performed a retrospective analysis
and showed no benefit for either implanted Doppler or microdialysis
over each other or clinical monitoring, although it did show a signifi-
cant increase in the false-positive rate when microdialysis was used as
a sole method of monitoring. In a prospective cohort study, Frost et al74
demonstrated that both microdialysis and the Cook-Swartz Doppler
probes detect flap compromise statistically earlier than the standard
clinical monitoring. Of note, microdialysis showed a superior detection
rate in comparison to the implantable probe (number needed to diag-
nose: 1.00 vs 1.05) and a higher specificity rate (100% vs 67%). Both
studies are not sufficiently powered to show flap salvage rate advan-
tages. Interestingly, Whitaker et al reported a high false-positive rate
of 8.5%, while Frost et al recorded 0%.
Major limitations of microdialysis are associated with its high
cost (USD 597 per flap) and its relatively high false-positive rate. Nielsen
et al reported that false-positive cases only occurred during the early
learning phase and are associated with technical issues that are signifi-
cantly reduced with the development of a decision algorithm to standard-
ize the process and the operator experience.90,92
Oximetry
Pulse oximetry is a simple, noninvasive technique that assesses
the oxygen saturation of arterial hemoglobin (SaO2) in real-time. De-
crease in oxygen saturation occurs significantly earlier than changes
in clinical signs after both venous and arterial occlusion.99 Hence, sev-
eral studies have attempted to use SaO2 as a measure of perfusion in free
flaps. Initial animal studies in 1979 showed oximetry to be a potential
predictor of flap survival.100,101 Successful use of transcutaneous SaO2
was tested in 1981,102 and since then, numerous studies of similar topics,
including the use of implanted oximetry probes and transflectance
probes, have been published.103–106 Although there are anecdotal re-
ports of flap compromise detected by implanted SaO2,
103–106 and other
studies showing successful use of implanted SaO2 probes,
105 no studies
have adequately demonstrated oximetry as having clear advantages
over clinical monitoring on the basis of flap salvage rate.
In the last decade, near-infrared spectroscopy (NIRS) has been
tested with promising results experimentally and clinically.107 The NIRS
has additional advantages over oximetry in that it can determine tissue
hemoglobin content, which may allow for clinical differentiation be-
tween arterial and venous occlusion.108 Tissue oxygen saturation mea-
sured by NIRS is reliable because it is not affected by external factors,
such as supplemental oxygen and blood pressure, and flap-specific var-
iables, such as the perforator size and number.109 Follow-up trials show
that detection of compromise often occurs before the clinical suspicion
of thrombosis.38,110–112 Furthermore, NIRS can eliminate the need for
a specialized intensive nursing care and, thus can reduce the cost.113
There have been 3 comparative studies evaluating the combination of
NIRS and clinical monitoring against clinical monitoring alone.33,34,39
All 3 studies reported high flap salvage rates (94%, 100%, and 100%,
respectively), but only 2 trials showed statistical significance.33,34 The
other study by Lohman et al37 included too few flap salvage attempts
(n = 5) to satisfy statistical analysis. The same authors report that NIRS
detects vascular compromise earlier and more reliably than other ad-
junctive monitoring methods, such as the handheld Doppler and im-
planted Doppler probes.37
Visible Light Spectroscope
In comparison to NIRS, visible light spectroscopy (VLS) is a
real-time, localized method that utilizes visible light to measure the he-
moglobin saturation at capillary level. Because visible light is absorbed
by hemoglobin 100 times more than infrared light, VLS is theoretically
more sensitive to alterations in tissue oxygenation than NIRS. Cornejo
et al38 first reported the application of VLS in free flap monitoring.39
The authors noted that VLS detected flap ischemia earlier than the im-
plantable Doppler probe and clinical examination. However, the only
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patient in the study was considered too unstable for reexploration, and
subsequent flap loss made it difficult to ascertain if early detection
could have resulted in flap salvage. There is only 1 comparative study
reported in the literature.40 These authors report that VLS detected flap
compromise 50 minutes before clinical assessment. The authors did not
report an impact on the flap salvage rate.
Mulitspectural Imaging
Multispectral spatial frequency domain imaging (SFDI) is a new
oxygenation imaging technique that enables visualization of oxygena-
tion over a large area of tissue. The SFDI detects alteration in oxygen
saturation secondary to partial blood flow obstruction earlier than visual
cutaneous changes.41 In animal studies, SFDI demonstrated accuracy
within 10% of Food and Drug Administration–approved oxygen satura-
tion probes.114,115 The first pilot study in a human patient confirmed its
safety and feasibility.114
Luminescence ratiometric oxygen imaging (LROI) is a new tech-
nique that measures relative transdermal oxygen consumption for quanti-
tative assessment of perfusion.116 The LROI consists of a fluorescent
oxygen sensory foil covering the cutaneous surface of a flap and a hand-
held fluorescence microscope. The sensory foil contains a reservoir of
oxygen, which is consumed by the tissue. In a prospective analysis of
52 free flaps, Meier et al concluded that relative transdermal oxygen
consumption of less than 0.3 indicates a well-perfused flap and greater
than 0.3 a poorly perfused flap.116 Mueller et al117 performed a pro-
spective study of 15 osseocutaneous flaps showing that using both
LROI and contrast-enhanced ultrasound (CEUS) can complement each
other where the CEUS assesses the deep tissues, such as bone, and
LROI evaluates the skin.
CO2 Monitoring
In addition to monitoring SaO2, Hashimoto et al
118 proposed the
use of CO2monitoring as a better method of detecting flap compromise,
but no follow-up study has been performed. Similarly, Jonas et al119
used a polarographic sensor to monitor the partial pressure of oxygen
and produced a salvage rate of 59%. This technique is invasive, how-
ever, and has not gained wide acceptability.
There is good evidence that the use of SaO2 and/or SaCO2
could be beneficial, but further studies involving a randomized clin-
ical trial is needed to demonstrate definitive clinical benefit of these
various techniques.
Laser Doppler Flowmetry
Laser Doppler flowmetry is a simple, noninvasive technique in
which the Doppler shift of a laser shone into a free flap is used to derive
the speed at which blood flows in the flap and give a measure of the tis-
sue perfusion. It is used in many experiments that require comparative
measurements of skin blood flow.119–126 The main advantages of this
method are that it can be used to monitor buried flaps and to provide
an immediate qualitative measure of the tissue blood flow. Anecdotally,
it provides a warning of flap compromise up to several hours before the
onset of clinical signs127 and has a low false-positive and -negative
rates.128 Possible causes of error that may arise using laser Doppler
flowmetry include the assumption that speed and velocity are similar
and the ignorance of random interstitial cell movement.129 Amajor lim-
itation of this technique is its depth of penetration (8 mm), restricting its
utility in monitoring buried flaps.
Some retrospective studies of units using this device show similar
flap salvage rates to units using clinical monitoring alone,130 whereas 1
study has shown an increase of salvage rate from 50% to 85% in a
group of 12 complicated flaps.35 This study represents CEBM level
2b evidence, the highest level of evidence available for laser Doppler.
Recent investigations using this technique have turned to a tissue
oxygen analysis system, called Oxygen to See (O2C, LeaMedizintechnik,
Giessen, Germany), combining the laser Doppler with white light spec-
trophotometry. The white light can additionally determine oxygenation
and the relative amount of hemoglobin. A significant advantage associ-
ated with O2C is that it enables differentiation between venous conges-
tion and arterial occlusion.108,131 In a prospective study of 34 patients
and 5 reexploration attempts, O2C produced 80% salvage rate, which
is favorable to the standard clinical monitoring.132 Recently, a prospec-
tive study by Mucke et al133 demonstrated that using O2C that during
early stages of the free flap integration, different parameters contribute
at different times. In the immediate postoperative period, both superfi-
cial and deep blood flow and velocity decrease below the baseline.
However, from the second postoperative day, a downward trend of these
parameters suggests a need for reexploration. The investigators further
demonstrated that oxygen saturation is not associated with ultimate flap
failure. Further studies with large numbers are needed to prove that this
method can alter flap salvage rates.
Fluorimetry
Initially used in 1940s to determine the viability of areas of
pedicled flaps, early studies showed that this method accurately pre-
dicted the survival of areas of pedicled flaps. Fluorimetry measures
the ultraviolet-induced fluorescence of fluorscein dye in tissue follow-
ing intravenous injection (arterial phase) and renal excretion (venous
phase). In tissue with a single artery and vein. These measurements as-
sess arterial and venous patency respectively.134 This technique was
later easily adapted for use in monitoring free flaps. The introduction
of fiberoptic fluorimetry by Silverman et al133,134 allowed for the
monitoring of elimination as well as perfusion with fluorescein.135–137
Subsequently, other studies showed that using oral fluorescein was pos-
sible.138,139 Fiberoptic measurement of fluorescein permitted use of
small dye doses and frequent reexaminations. Monitoring 200 free
flaps, Whitney et al28 demonstrated a sensitivity of 91% and an increase
in flap salvage rate from 55% (with clinical monitoring) to 85%, with
the control being free flaps performed before the introduction of fluo-
rimetry to the unit.28 This study was particularly important because it
is one of the earliest studies in the literature directly comparing an ad-
junctive monitoring technique to clinical monitoring.
Issing and Naumann136 showed that fluorimetry was a more
specific indicator of flap survival than either pH monitoring or surface
temperature monitoring.138 This technique is extremely sensitive and is
able to detect areas of flap necrosis as well as thrombosis within the
pedicle.138 However, monitoring requires expertise and the injection of
fluorescein has the potential for adverse effects, including anaphazis.
The use of indocyanide green (ICG) may be safer than fluores-
cein, and initial results are promising.139–142 Mothes et al143 studied
the use of ICG fluorescence angiography (ICG-FA) both intraopera-
tively and postoperatively and concluded that this technique was useful
intraoperatively but no better than clinical monitoring postoperatively.
Furthermore, anaphylactic reaction to the ICG has been reported in
the literature, and it is contraindicated in patients with iodine allergy.144
In recent times, ICG-FA has been used more frequently for intraoperative
assessment of microvascular circulation in free flap operations.145,146
Fluorimetry is one of the few techniques in the current literature to
provide CEBM level 2 evidence for an adjunctive monitoring technique.
Reasons for its limited applicability include adverse reactions, nursing
work demands, and its inefficacy with muscle tissue and pigmented skin.28
Temperature Measurement
Temperature measurement was first discussed in a review by
Harrison et al147 in 1981. This technique is one of the oldest and the
simplest adjunctive monitor methods. In 1983, May et al148 used
an implanted temperature probe on the vascular pedicle to monitor
flaps. This idea showed promise, but there have been no subsequent
studies to determine the effectiveness of this technique. Issing and
Naumann138 showed that temperature changes were significant, only
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after 15 hours of flap ischemia, a period far too long for a flap to be
successfully revascularized.
One of the major problems with surface temperature monitoring
is the difficulty in properly controlling results. Skin surface temperature
fluctuates by asmuch as 8°C in normal subjects, depending on clothing,
humidity, core temperature, room temperature, and many other factors.
Khouri and Shaw149 showed in a retrospective analysis that a properly
controlled comparison of flap skin temperature to a control temperature
yielded 98% sensitivity and 75% specificity for anastomotic blockage.
Chiu et al150 suggested using adhesive temperature strips as an inexpen-
sive adjunct, but not a replacement, to the standard clinical monitoring.
Recently, Kannan151 reported a modified technique using a standard
digital thermometer where a decrease in the skin surface temperature
in the center of the flap compared to the surrounding skin was signifi-
cant for an arterial occlusion. Their findings would need to be re-
produced in large clinical studies and require statistical support.
In place of the traditional thermometers, some investigators report
their use of the infrared thermometers,152–155 a noncontact technique
that is more sensitive than the implantable and the surface contact ther-
mometers. Anecdotal reports demonstrate that flap areas with lower
temperature are associated with areas of later necrosis.152,153 In a retro-
spective analysis, Papillion et al154 reported using an infrared thermom-
eter, and that the flap surface temperature starts to decrease 8 hours
postoperatively with a mean reduction of 2°C is observed in failed free
flaps. Their findings are supported by a clinical trial where the free
flap temperature measured by a digital infrared thermometer correlated
with alteration in the capillary blood flow and hemoglobin oxygenation
measured by O2C (Lea Medizintechnik, Giessen, Germany).155 The
authors concluded that a decrease greater than 3°C in the flap skin
temperature compared to the surrounding skin is significant for an arte-
rial, but not venous, thrombosis. Furthermore, a reduction of 3°C in the
center of the flap indicated arterial occlusion and a reduction of 1°C to
2°C venous compromise. The current consensus is that infrared ther-
mometers are a simple, inexpensive, reliable adjunctive method in post-
operative monitoring of free flaps; this would need to be supported in
the setting of a larger clinical trial.
Glucose and Lactate Measurement
Measuring the flap glucose level and lactate is a cheap, simple,
and rapid method of predicting microvascular complications in free flaps.
In amulticenter clinical trial, Henault et al42 used flap glucose levels of less
than 3.85 mmol/L and lactate levels greater than 6.4 mmol/L to indicate
pedicle compromise. This technique yielded sensitivity of 98.5% and
specificity of 99.5%. Changes in glucose and lactate level occurred in av-
erage 5.7 hours before the onset of clinical signs. Hara et al156,157 reported
high sensitivity and specificity when only flap glucose level was used to
detect venous thrombosis. Di Lorenzo et al158 calculated a ratio of flap
glucose to systemic glucose level and demonstrated its accuracy in iden-
tifying both arterial and venous occlusions requiring reanastomosis. It is
yet unclear why flap glucose level drops as a result of pedicle compro-
mise.159,160 It is hypothesized that a reduction of blood supply to a com-
promised flap leads to a shortage of tissue glucose supply.161
Smartphone Applications and Telecommunication
In the era of readily accessible Internet and ubiquitous smart-
phones with camera functionality,162,163 digital photography represents
an opportunity for surgeons to monitor free flaps remotely, enable rapid
communication between nursing and medical staff, and potentially
TABLE 1. Factors Affecting Types of Monitoring Techniques Used
Method Cost Availability Ease of Application Time to Diagnosis
Clinical +++ +++ +++ Medium
Implanted ultrasound (Cook-Swartz probe) + ++ ++ Short
Microdialysis + + + Medium
Implanted pO2 ++ + + Short
NIRS + ++ ++ Short
VLS + ++ ++ Short
SFDI + + + Short
LROI ++ + ++ Short
Laser Doppler ++ ++ ++ Short
Fluorimetry ++ + + Long
Implanted temperature ++ + + Long
Surface temperature +++ +++ +++ Long
Glucose & lactate +++ +++ +++ Short
Smartphones ++ +++ +++ Short
PPG ++ + ++ Short
Handheld Doppler ++ ++ + Medium
Color Doppler + + +++ Medium
CEUS + + + Medium
Impedance plethysmography ++ + + Short
SDFI + + ++ Short
Confocal microscopy + + + Medium
Orthogonal polarized light + + + Short
Scintigraphy + ++ + Long
PET + + + Long
pH ++ + + Medium
Hydrogen clearance + + ++ Short
pO2 indicates partial pressure of oxygen.
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reduce the response time to reexploration.42 There have been 2 compar-
ative studies.36,164 Hwang and Mun36 compared the clinical outcome
before and after their unit adopted an instantaneous Internet messaging
service to share digital photos of postoperative free flaps. The flap salvage
rate improved (100% vs 50%) and the response time to reexploration re-
duced significantly (1.4 hours vs 4.0 hours). These elements translated to
a higher rate of overall flap survival (100% vs 96.2%). A prospective
study by Engel et al161 who also reported a significant decrease in the
response time using remote digital photography over “in-person exam-
ination” (8 minutes vs 180 minutes).164 Recently, Kiranantawat et al165
have developed a smartphone application that analyzes digital photos
for color difference and demonstrated high sensitivity (94%) and spec-
ificity (98%) in detecting vascular compromise.
As the integration of smartphone and telemedicine becomes
commonplace in plastic surgery, Gardiner and Hartzell166 suggest that
despite 96% of publications from their literature review displaying its
benefit, a significant 51% documented adverse effects, such as techni-
cal issues, cost, misdiagnosis, and learning curve for a new technology.
Furthermore, with the storage of clinical photography and other poten-
tially patient-identifiable information in personal electronic devices,
there may arise legal issues associated with privacy and security requir-
ing resolution before a wide adoption of this technology.
Photoplethysmography
Similar to SaO2 monitoring, photoplethysmography (PPG) uses
reflected spectrographic means (either green or infrared light) to deter-
mine real-time perfusion. However, PPG directly measures the flux of
red blood cells, rather than a mathematical derivative of SaO2 flux,
which is the technique used by NIRS. Recent development of a
custom-made photoplethysmographic and pulse oximetry optical and
fiber-optical probe and the processing system has enabled direct contin-
uous monitoring of arterial oxygen saturation in real time.167,168 The
PPG demonstrates much higher correlations to radioactive microsphere
measurements than laser Doppler flowmetry and is, hence, very accu-
rate.169 Clinical testing has shown high sensitivity and specificity in a
blinded clinical trial.170 Anecdotal reports show that this device may be
able to reliably determine successful tissue perfusion in situations when
both clinical and duplex Doppler assessment could not rule out flap com-
promise.171,172 It appears that this extremely sensitive device holds prom-
ise, but further clinical trials are required to demonstrate its efficacy.
Ultrasound
Handheld Doppler ultrasound probes are the most commonly
used adjunct to the clinical examination in assessing pedicle flow,173
but it has not been evaluated as a stand-alone technique apart from its
application in the implantable Cook-Swartz Doppler probe. One of
the major disadvantages associated with the handheld Doppler devices
is that it is difficult to differentiate between the pedicle and the adjacent
vessels in the recipient site, and also, between arterial and venous flow.
These issues are compounded by the presence of anastomotic couplers
and in buried flaps. Color Doppler ultrasound can be advantageous. It is
a noninvasive bedside technique that can accurately demonstrate flow
and flap viability.174 Furthermore, it can provide objective assessment
of perfusion in buried flaps.175 In addition, color Doppler probes can
be used to estimate the resistance to flow and produce a pulsatility in-
dex, which is a widely accepted alternative to measuring flow.176 The
authors reported that venous compromise is associated with a signifi-
cantly high pulsatility index.
TABLE 2. Characteristics of Monitoring Techniques
Method Sensitivity
Detect Arterial or
Venous Compromise
Differentiate Arterial Versus
Venous Compromise
Differentiate Territorial Versus
Pedicle Compromise
Clinical High Venous > arterial Yes Yes
Implanted ultrasound (Cook-Swartz probe) High Both No Yes
Microdialysis High Both Yes No
Implanted pO2 Medium Both No No
NIRS High Both Yes Yes
VLS High Both No No
SFDI High Both Unknown No
LROI High Both No Yes
Laser Doppler High Both Yes Yes
Fluorimetry High Both Yes Yes
Implanted temperature Medium Arterial > venous No No
Surface temperature Medium Arterial > venous No No
Glucose & lactate High Both Unknown No
Smartphones High Venous > arterial Yes Yes
PPG High Both Yes Yes
Handheld Doppler Medium Arterial > venous No No
Color Doppler High Both Yes Yes
CEUS High Both Yes Yes
Impedance plethysmography High Both Yes No
SDFI High Both Unknown No
Confocal microscopy High Both Yes Yes
Orthogonal polarized light High Unknown Unknown Yes
Scintigraphy High Both No Yes
PET High Both No No
pH High Both No No
Hydrogen clearance High Both Yes No
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Recent studies using ultrasound contrast media (SonoVue,
Bracco, Italy) have shown that CEUS used to measure dermal microcir-
culation correlates highly with the results obtained from ICG-FA,177
fluoride positron emission tomography (PET),178 and contrast-enhanced
magnetic resonance imaging.179,180 The CEUS is quick and noninva-
sively monitors the anastomoses of a free flaps,181 including bone
flaps.182 One of the major advantages of CEUS is that it provides both
qualitative assessment of the capillary perfusion in different flap areas
and quantitative analysis using parameters derived from a special perfu-
sion software QONTRAST (Bracco, Italy), such as time to PEAK and
regional blood volume.183,184 Furthermore, Sharma et al185 demon-
strated that both qualitative and quantitative assessments by CEUS
are associated with high sensitivity (100% and 100%, respectively)
and specificity (86% and 100%) in predicting flap failure. In a recent
retrospective analysis, Geis et al186 demonstrated that vascular compli-
cations estimated by QONTRASTand CEUS produced a high flap sal-
vage rate of 85%. Potential issues with CEUS include the repeated
exposure to contrast media and the potentially long period of time be-
tween clinical suspicion of compromise and an ultrasound examination
of a flap. Until they are tested in large clinical trials, all ultrasound tech-
niques currently remain best used as an adjunct to clinical assessment
and for reassurance in borderline cases.
Impedance Plethysmography
The assessment of thoracic blood flow by electrical impedance is
an established research technique. In an application of this technique, a
small electrode array has been developed in which an alternating elec-
tric current is passed through a cutaneous free flap and the induced volt-
age across a small volume measured. A graphical display of this
changing voltage illustrates the pulsatile flow through the flap, allowing
continuous assessment of perfusion. According to the original articles
describing this technique, it is accurate, easily interpreted, and usable
by inexperienced staff.187,188 Studies in animals showed that analysis
of results by an investigator blinded to the status of the pedicle could
quickly determine pedicle obstruction and accurately determine venous
or arterial blockage in 100% of cases.189 However, the technique is in-
vasive, and no comparative clinical study has yet been reported.
Sidestream Dark Field Imaging
Sidestream Dark Field Imaging (SDFI) is a new noninvasive
technique that evaluates end-capillary microcirculation at the cellular
level. A central light guide is surrounded by concentrically placed stro-
boscopic light-emitting diodes to provide sidestream dark field illumi-
nation. It produces a real-time visualization of the red blood cells,
independent of their oxygenation status, and all other cells found in the
blood stream.190 The main advantages of SDFI are that it provides a di-
rect measure of blood flow to the flap and requires minimal training.
To date, its use in postoperative free flap monitoring has only been dem-
onstrated in animal studies191 and a case report.192 The authors of the
clinical report suggest that SDFI may be useful in patients with
pigmented skin where clinical examination of skin capillary refill is dif-
ficult to assess accurately.192
TABLE 3. Currently Available Levels of Evidence for Monitoring Techniques
Method
Best Reported
False-Positive Rate
Best Reported
True-Positive Rate
Highest Level of Evidence
Regarding Flap Salvage Rate
Highest Reported Flap
Salvage Rate (No. Cases)
Clinical NR NR Current standard 77% (57)
Implanted ultrasound (Cook-Swartz probe) 0.9% 100% 2a 100% (16)
Microdialysis 0% 100% 4 NR
Implanted pO2 NR NR 4 NR
NIRS 0% 100% 2b 100% (3)
VLS NR NR 4 NR
SFDI NR NR 5 NR
LROI NR NR 4 NR
Laser Doppler 0% 100% 2b 83% (12)
Fluorimetry 6% 91% 2b 86% (23)
Implanted temperature NR NR 4 NR
Surface temperature 25% 98% 2b NR
Glucose & lactate NR NR 2b NR
Smartphones 1% NR 3 100% (4)
PPG 4% 95% 4 NR
Handheld Doppler N/A N/A N/A N/A
Color Doppler NR 100% 4 NR
CEUS NR NR 4 NR
Impedance plethysmography NR 100% 5 NR
SDFI NR NR 5 NR
Confocal microscopy NR NR 5 NR
Orthogonal polarized light N/A N/A 5 NR
Scintigraphy NR NR 5 NR
PET NR NR 4 NR
pH NR NR 4 NR
Hydrogen clearance NR NR 4 NR
NR indicates not reported; N/A, no relevant studies.
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Confocal Microscopy
Confocal microscopy is a well-known laboratory technique that
uses laser technology to create virtual sections of a tissue, an application
of which is the evaluation of the capillary beds of free flaps. The eval-
uation of these capillaries postoperatively is a means of perfusion
assessment, with both arterial and venous compromise potentially dif-
ferentiated by this method. It has been shown that venous obstruction
results in a significant dilatation of the capillaries and thickening of
the epidermis caused by edema, and flow across the capillary beds is
significantly reduced in both arterial venous compromise.193 Currently,
there are no clinical studies evaluating this technique in postoperative
free flap monitoring.
Orthogonal Polarized Light
This relatively new technique involves the use of polarized light to
determine the state of the microcirculation in the skin. Polarized green
(548 nm) light is shone onto the skin, and a certain proportion of this light
is reflected back toward the source. A beam splitter directs the light
through a second polarizer placed at 90° to the original polarization of
the light. As a result, only light that has undergone a change in its polar-
ization caused by Rayleigh scattering by hemoglobin can be visualized. It
is estimated that the light must undergo 10 or more scattering events be-
fore it can be depolarized enough to pass through the second filter,194 and
so the depolarized light is assumed to have penetrated relatively deeply.
This use of cross-polarization allows for high-contrast viewing of the mi-
crovasculature in skin, and for analyses of perfusion to be performed. An-
imal studies have shown this technique to accurately predict flap necrosis,
and several investigators postulate this technique's usefulness in flap
monitoring. However, no clinical studies on free flap monitoring have
been performed utilising this modality.195–197
Nuclear Medicine
Radioactive isotopes can be used as direct measures of tissue
perfusion. The injection of an isotope can be later measured by scintig-
raphy or PET, with the assumption that the isotope is metabolically
inactive and that it diffuses freely in the tissues being monitored. One
advantage of this technique is that scintigraphy images can show areas
of partial flap hypoperfusion. Several different isotopes have been
studied,147,198–201 including 85Kr, 133Xe, 22Na, and 99mTc. Aygit and
Sarikaya200 demonstrated that this technique was useful in determining
flap viability, but note was made of several problems with this tech-
nique, making it ultimately unlikely to be useful in monitoring of flaps.
Aside from issues related to access to nuclear medicine laboratories, the
technique also requires a reasonable amount of time between the injec-
tion of radioactive agent and scintigraphy to allow isotope diffusion.
This substantial time delay is likely to reduce its clinical benefit and un-
likely to improve flap salvage rates.
Positron emission tomography imaging is a sensitive technique,
which uses radiolabeled glucose to derive metabolic state of a tissue. As
a postoperative monitoring technique in free flap reconstructions, radio-
active water can be injected, instead, to quantify blood flow.202,203 In a
prospective study, Schrey et al202 calculated the blood flow in a radial
forearm free flap and the muscle on the contralateral forearm. They
demonstrate that a low flap-to-muscle blood flow ratio predicts poor
success of the entire flap. In a later study,203 the same authors suggest
that PET imaging is a useful adjunct where the flap is difficult to access
for adequate clinical assessment and other monitoring methods, such as
tissue oximetry probes, and where the indication to reexplore is equiv-
ocal. Similar to scintigraphy, practical application of PET in the imme-
diate postoperative period is limited by its cost, access to a PET scan,
and a potential time delay to reexploration. Furthermore, PET intro-
duces exposure to radiation. Positron emission tomography may have
a greater role for flap monitoring in the late postoperative setting.204
pH Measurement
In 1983, Raskin et al205 first introduced the use of an implanted
removable pH monitor. They showed in animal experiments that pH
values decrease shortly after the onset of arterial occlusion. Dickson
and Sharpe206 showed that therewas a similar decrease in pH during ve-
nous occlusion, again in animal studies. Dunn et al207 conducted a
small clinical study, in which pH monitoring pre-empted both clinical
monitoring and Doppler ultrasound. Issing and Naumann138 showed
that this method was not as precise as fluorescein injection to demon-
strate flap viability, but pH monitoring had several other advantages.
It is fast, inexpensive, and can be used as a continuous monitor. There
is no evidence that this technique changes flap salvage rates, and further
studies are needed to demonstrate clinical efficacy.
Hydrogen Clearance
This technique uses the changing impedance of the body be-
cause of H2 concentration within tissues. The decay of H2 concentration
in the tissue of interest is registered by electrodes. Mathematical analy-
sis of clearance allows quantitative expression of blood flow values in
milliliters per minute per 100 g of tissue. This technique is of interest
because it is relatively simple, safe, can provide instantaneous results
at many points in time, can measure perfusion within a buried flap,
and is also a direct measure of tissue perfusion. There has been only 1
clinical study evaluating this technique, which although small (n = 9),
demonstrated that hydrogen clearance measurement detected changes
in blood flow earlier than clinical monitoring and was able to distin-
guish between arterial and venous outflow blockage.208 This technique
remains a potentially useful method, but more studies are required to
demonstrate that it may influence clinical outcomes.
DISCUSSION
Only 5 monitoring techniques have shown any evidence for im-
provement of flap salvage rates. In limited studies, the Cook-Swartz
implantable Doppler, NIRS, laser Doppler flowmetry, quantitative fluo-
rimetry, and digital smartphone assessments have demonstrated either
comparative or historical flap salvage improvement compared to clinical
monitoring. None of these studies, however, has reached a level of evi-
dence or a configuration of results leading to widespread clinical use.
There have been a plethora of objective and subjective methods
for flap monitoring, with each having unique advantages. When deriv-
ing an objective comparison between the monitoring techniques and
utilizing an adapted version of the criteria that Creech andMiller26 sug-
gested, several key findings are noted. Tables 1 and 2 display individual
characteristics of each technique that may be particularly useful to an in-
dividual microsurgical unit. Table 1 reflects the cost and ease of use in
general terms, whereas Table 2 identifies the intrinsic properties of the
different types of monitoring techniques. The benefits of adjunctive
monitoring methods lie in their ability to improve outcomes, compared
to clinical monitoring alone. In Table 3, the evidence in the available lit-
erature is provided that supports each technique. The best available statis-
tics for each technique is provided and the “level of evidence” for
different methods in Table 3 refer to the Oxford CEBM Levels of Evi-
dence (March 2009). This specifically describes the highest level of evi-
dence available that a particular technique changes the flap salvage rate.
Of note, most of available literature on flap monitoring does not
provide objective evaluation of the monitoring techniques. Despite the
fact that flap salvage rate is a significant attribute of a technique that in-
dicates its usefulness, it is evident from Table 3 that flap salvage rate is
the characteristic that received the least attention. Furthermore, most of
the currently available studies do not use clinical relevant end points to
determine successes of their monitoring techniques.27 Future studies
must report clinically relevant parameters, such as the flap salvage rate
and the false-positive rate, which enables objective comparison between
different monitoring techniques.
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